Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
- PMID: 33797951
- PMCID: PMC8140795
- DOI: 10.1200/CCI.20.00148
Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
Abstract
Purpose: Informatics solutions to early diagnosis of cancer in primary care are increasingly prevalent, but it is not clear whether existing and planned standards and regulations sufficiently address patients' safety nor whether these standards are fit for purpose. We use a patient safety perspective to reflect on the development of a computerized cancer risk assessment tool embedded within a UK primary care electronic health record system.
Methods: We developed a computerized version of the CAncer Prevention in ExetER studies risk assessment tool, in compliance with the European Union's Medical Device Regulations. The process of building this tool afforded an opportunity to reflect on clinical concerns and whether current regulations for medical devices are fit for purpose. We identified concerns for patient safety and developed nine practical recommendations to mitigate these concerns.
Results: We noted that medical device regulations (1) were initially created for hardware devices rather than software, (2) offer one-shot approval rather than supporting iterative innovation and learning, (3) are biased toward loss-transfer approaches that attempt to manage the fallout of harm instead of mitigating hazards becoming harmful, and (4) are biased toward known hazards, despite unknown hazards being an expected consequence of health care as a complex adaptive system. Our nine recommendations focus on embedding less-reductionist and stronger system perspectives into regulations and standards.
Conclusion: Our intention is to share our experience to support research-led collaborative development of health informatics solutions in cancer. We argue that regulations in the European Union do not sufficiently address the complexity of healthcare information systems with consequences for patient safety. Future standards and regulations should continue to follow a system-based approach to risk, safety, and accident avoidance.
Figures
References
-
- Emery JD Shaw K Williams B, et al. : The role of primary care in early detection and follow-up of cancer. Nat Publ Gr 11:38-48, 2014 - PubMed
-
- US Food and Drug Administration : Software as a Medical Device (SAMD): Clinical Evaluation Guidance for Industry and Food and Drug Administration Staff. FDA Guid, 2017, pp 1-32. https://www.fda.gov/media/100714/download
-
- The European Parliment and The Council of the European Union : Council Directive 93/68/EEC of 22 July 1993. Off J Eur Union 68, 1993
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
